- Home
- FITBO vs MRK Comparison
FITBO vs MRK Comparison
Compare FITBO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FITBO
Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Current Price
Company Overview
Basic Information| Metric | FITBO | MRK |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | 18616 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 260.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FITBO | MRK |
|---|---|---|
| Price | $19.63 | $101.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $111.93 |
| AVG Volume (30 Days) | N/A | ★ 15.2M |
| Earning Date | N/A | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.38% |
| EPS Growth | N/A | ★ 58.08 |
| EPS | N/A | ★ 7.56 |
| Revenue | N/A | ★ $64,235,000,000.00 |
| Revenue This Year | N/A | $1.97 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | ★ N/A | $13.33 |
| Revenue Growth | N/A | ★ 1.68 |
| 52 Week Low | N/A | $73.31 |
| 52 Week High | N/A | $105.84 |
Technical Indicators
Market Signals| Indicator | FITBO | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 60.44 |
| Support Level | $19.32 | $96.79 |
| Resistance Level | $19.71 | $100.94 |
| Average True Range (ATR) | 0.21 | 2.32 |
| MACD | 0.05 | -0.45 |
| Stochastic Oscillator | 76.92 | 72.71 |
Price Performance
Historical ComparisonAbout FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).